Ajax's lead asset, AJ1-11095, is an investigational, once-daily oral, first-in-class Type II JAK2 inhibitor currently being evaluated in a Phase 1 clinical trial.
David Basile of Hovione discusses expanded spray drying capacity in East Windsor and the benefits of integrated development, scale-up, and manufacturing at a single U.S. site.
Under the collaboration, BD’s device-agnostic combination product testing organization is complemented by Sutton’s Creek combination product development and systems integration expertise.
Sentry BioPharma Services, Inc. (Sentry US) protects product SISPQ by offering compliant pharmaceutical services, including cGMP temperature-controlled storage, controlled substance management (CS III-V), clinical/commercial labeling and secondary packaging. Sentry also provides import/export optimization by leveraging our end-to-end GxP logistics, global distribution and Foreign Trade Zone expertise. Sentry’s status as a US Foreign Trade Zone enables products from outside the United States to be received and held within cGMP storage, pending approval for importation from the FDA, CBP and DEA. Sentry is VAWD accredited, licensed in all US states and inspected by the FDA, along with numerous international authorities. Sentry’s newest facility in Columbus, IN provides stock splitting risk mitigation services and will offer additional cGMP offerings in 2026.
August Bioservices is a US-based CDMO focused on delivering high-quality development and manufacturing solutions for sterile injectables. With state-of-the-art facilities and advanced technical expertise, August Bio offers a seamless integration of services that span from early-stage development to commercial-scale production.
